N~2~-1,3-benzoxazol-2-yl-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-L-alaninamide

N~2~-1,3-benzoxazol-2-yl-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-L-alaninamide is a synthetic small molecule belonging to the class of alpha amino acid amides and benzoxazoles. It has a molecular formula of C25H32N4O3 and a molecular weight of approximately 436.55 g/mol[1][2][3]. The compound is experimental and not approved for clinical use in any country[1]. Its structure features a benzoxazole moiety linked to an alaninamide backbone with cyclohexyl and methoxyphenylaniline substituents. There are no reported clinical indications or advanced development status for this molecule, and its mechanism of action has not been established in the literature or major chemical databases as of June 2025[1][5].

Other names

(2S)-2-(1,3-benzoxazol-2-ylamino)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamideDB07839DB-07839DB 07839CID 6420159CID6420159CID-6420159